CervoMed Inc [CRVO] stock prices are up 22.53% to $11.91 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CRVO shares have gain 10.28% over the last week, with a monthly amount drifted -7.24%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CervoMed Inc [NASDAQ: CRVO] stock has seen the most recent analyst activity on December 06, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $45. Previously, H.C. Wainwright started tracking the stock with Buy rating on December 05, 2024, and set its price target to $42. On September 18, 2024, Chardan Capital Markets initiated with a Buy rating and assigned a price target of $55 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $35 on July 26, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $50 as its price target on February 15, 2024. H.C. Wainwright downgraded its rating to Neutral for this stock on November 17, 2020. In a note dated March 21, 2018, H.C. Wainwright initiated an Buy rating and provided a target price of $1.25 on this stock.
The stock price of CervoMed Inc [CRVO] has been fluctuating between $5.85 and $26.38 over the past year. Currently, Wall Street analysts expect the stock to reach $16.32 within the next 12 months. CervoMed Inc [NASDAQ: CRVO] shares were valued at $11.91 at the most recent close of the market. An investor can expect a potential return of 37.03% based on the average CRVO price forecast.
Analyzing the CRVO fundamentals
The CervoMed Inc [NASDAQ:CRVO] reported sales of 10.07M for trailing twelve months, representing a surge of 27.07%. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -1.66%, Pretax Profit Margin comes in at -1.47%, and Net Profit Margin reading is -1.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.44 and Total Capital is -0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.87 points at the first support level, and at 7.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.17, and for the 2nd resistance point, it is at 16.44.
Ratios To Look Out For
It’s worth pointing out that CervoMed Inc [NASDAQ:CRVO]’s Current Ratio is 15.04. On the other hand, the Quick Ratio is 15.04, and the Cash Ratio is 2.39. Considering the valuation of this stock, the price to sales ratio is 11.96, the price to book ratio is 2.15.
Transactions by insiders
Recent insider trading involved ELDER WILLIAM ROBERT, CFO & GC, that happened on Aug 27 ’24 when 1000.0 shares were purchased.
